BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21945767)

  • 21. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
    Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
    J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of specific prostanoid EP receptor agonists on cell proliferation and intracellular Ca(2+) concentrations in human airway smooth muscle cells.
    Mori A; Ito S; Morioka M; Aso H; Kondo M; Sokabe M; Hasegawa Y
    Eur J Pharmacol; 2011 May; 659(1):72-8. PubMed ID: 21397595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
    Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
    J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PGE
    Zang S; Ma X; Wu Y; Liu W; Cheng H; Li J; Liu J; Huang A
    Hum Pathol; 2017 May; 63():120-127. PubMed ID: 28300577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prostaglandin E2 inhibits platelet-derived growth factor-stimulated cell proliferation through a prostaglandin E receptor EP2 subtype in rat hepatic stellate cells.
    Koide S; Kobayashi Y; Oki Y; Nakamura H
    Dig Dis Sci; 2004 Sep; 49(9):1394-400. PubMed ID: 15481309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin E2 modulates dendritic cell function via EP2 and EP4 receptor subtypes.
    Harizi H; Grosset C; Gualde N
    J Leukoc Biol; 2003 Jun; 73(6):756-63. PubMed ID: 12773508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
    Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
    Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandin E receptor subtypes in mouse osteoblastic cell line.
    Suda M; Tanaka K; Natsui K; Usui T; Tanaka I; Fukushima M; Shigeno C; Konishi J; Narumiya S; Ichikawa A; Nakao N
    Endocrinology; 1996 May; 137(5):1698-705. PubMed ID: 8612504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
    Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
    FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidermal growth factor stimulates the proliferation of human esophageal squamous cell carcinoma HKESC-1 cells by increasing COX-2 expression].
    Yu L; Cho CH; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1323-6. PubMed ID: 21868314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E₂ inhibits human lung fibroblast chemotaxis through disparate actions on different E-prostanoid receptors.
    Li YJ; Wang XQ; Sato T; Kanaji N; Nakanishi M; Kim M; Michalski J; Nelson AJ; Sun JH; Farid M; Basma H; Patil A; Toews ML; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):99-107. PubMed ID: 20203295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease.
    Cahill KN; Raby BA; Zhou X; Guo F; Thibault D; Baccarelli A; Byun HM; Bhattacharyya N; Steinke JW; Boyce JA; Laidlaw TM
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):34-40. PubMed ID: 26051534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium butyrate induces the production of cyclooxygenases and prostaglandin E₂ in ROS 17/2.8 osteoblastic cells.
    Iida T; Kawato T; Tanaka H; Tanabe N; Nakai K; Zhao N; Suzuki N; Ochiai K; Maeno M
    Arch Oral Biol; 2011 Jul; 56(7):678-86. PubMed ID: 21281931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 (PGE2) downregulates interleukin (IL)-1alpha-induced IL-6 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells.
    Noguchi K; Maeda M; Ruwanpura SM; Ishikawa I
    Oral Dis; 2005 May; 11(3):157-62. PubMed ID: 15888106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The soluble EP2 receptor FuEP2/Ex2 suppresses endometrial cancer cell growth in an orthotopic xenograft model in nude mice.
    Takahashi T; Ogawa H; Izumi K; Uehara H
    Cancer Lett; 2011 Jul; 306(1):67-75. PubMed ID: 21419570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptor-mediated increase in intracellular cyclic AMP.
    Aronoff DM; Canetti C; Peters-Golden M
    J Immunol; 2004 Jul; 173(1):559-65. PubMed ID: 15210817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E(2) promotes cell proliferation via protein kinase C/extracellular signal regulated kinase pathway-dependent induction of c-Myc expression in human esophageal squamous cell carcinoma cells.
    Yu L; Wu WK; Li ZJ; Li HT; Wu YC; Cho CH
    Int J Cancer; 2009 Dec; 125(11):2540-6. PubMed ID: 19623651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
    Wang XS; Lau HY
    Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2, prostaglandin E2, and prostanoid receptor EP2 in fluid flow shear stress-mediated injury in the solitary kidney.
    Srivastava T; Alon US; Cudmore PA; Tarakji B; Kats A; Garola RE; Duncan RS; McCarthy ET; Sharma R; Johnson ML; Bonewald LF; El-Meanawy A; Savin VJ; Sharma M
    Am J Physiol Renal Physiol; 2014 Dec; 307(12):F1323-33. PubMed ID: 25234310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.